125 related articles for article (PubMed ID: 22646987)
1. Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhood.
Paleari D; Rossi GA; Nicolini G; Olivieri D
Expert Opin Drug Discov; 2011 Nov; 6(11):1203-14. PubMed ID: 22646987
[TBL] [Abstract][Full Text] [Related]
2. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
Miyata T
Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
[TBL] [Abstract][Full Text] [Related]
3. Biofilm-dependent airway infections: a role for ambroxol?
Cataldi M; Sblendorio V; Leo A; Piazza O
Pulm Pharmacol Ther; 2014 Aug; 28(2):98-108. PubMed ID: 24252805
[TBL] [Abstract][Full Text] [Related]
4. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
5. The pharmacology of ambroxol--review and new results.
Disse BG
Eur J Respir Dis Suppl; 1987; 153():255-62. PubMed ID: 3322865
[TBL] [Abstract][Full Text] [Related]
6. An overview of efficacy and safety of ambroxol for the treatment of acute and chronic respiratory diseases with a special regard to children.
Kantar A; Klimek L; Cazan D; Sperl A; Sent U; Mesquita M
Multidiscip Respir Med; 2020 Jan; 15(1):511. PubMed ID: 32269775
[No Abstract] [Full Text] [Related]
7. Safety of ambroxol in the treatment of airway diseases in adult patients.
Cazan D; Klimek L; Sperl A; Plomer M; Kölsch S
Expert Opin Drug Saf; 2018 Dec; 17(12):1211-1224. PubMed ID: 30372367
[TBL] [Abstract][Full Text] [Related]
8. [The new possibility for the treatment of acute cough].
Klyachkina IL
Vestn Otorinolaringol; 2015; 80(5):85-90. PubMed ID: 26525480
[TBL] [Abstract][Full Text] [Related]
9. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
[TBL] [Abstract][Full Text] [Related]
10. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
[TBL] [Abstract][Full Text] [Related]
11. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
Wiessmann KJ; Niemeyer K
Arzneimittelforschung; 1978; 28(5a):918-21. PubMed ID: 373777
[TBL] [Abstract][Full Text] [Related]
12. [Modification of mucociliary clearance by a combination of theophylline with ambroxol and of ambroxol in monotherapy].
Dorow P; Weiss T
Arzneimittelforschung; 1988 Jun; 38(6):828-30. PubMed ID: 3052462
[TBL] [Abstract][Full Text] [Related]
13. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
[TBL] [Abstract][Full Text] [Related]
14. Influence of surfactant on mucociliary transport.
Allegra L; Bossi R; Braga P
Eur J Respir Dis Suppl; 1985; 142():71-6. PubMed ID: 3860399
[TBL] [Abstract][Full Text] [Related]
15. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
Disse B
Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic study on ambroxol in chronic bronchopulmonary diseases (author's transl)].
Curti PC; Renovanz HD
Arzneimittelforschung; 1978; 28(5a):922-5. PubMed ID: 581991
[TBL] [Abstract][Full Text] [Related]
18. Cell-specific modulation of surfactant proteins by ambroxol treatment.
Seifart C; Clostermann U; Seifart U; Müller B; Vogelmeier C; von Wichert P; Fehrenbach H
Toxicol Appl Pharmacol; 2005 Feb; 203(1):27-35. PubMed ID: 15694461
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of human neutrophil histotoxicity by ambroxol: evidence for a multistep mechanism.
Ottonello L; Arduino N; Bertolotto M; Dapino P; Mancini M; Dallegri F
Br J Pharmacol; 2003 Oct; 140(4):736-42. PubMed ID: 14534155
[TBL] [Abstract][Full Text] [Related]
20. [Ambroxol, studies of biotransformation in man and determination in biological samples (author's transl)].
Jauch R; Bozler G; Hammer R; Koss FW; Karlsson M; Vitek E; Häring I; Beschke K; Hadamovsky S; Maass D; Wollmann R
Arzneimittelforschung; 1978; 28(5a):904-11. PubMed ID: 581989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
